Advanced glycation end-product pentosidine is not a relevant marker of disease activity in patients with rheumatoid arthritis.

@article{enolt2007AdvancedGE,
  title={Advanced glycation end-product pentosidine is not a relevant marker of disease activity in patients with rheumatoid arthritis.},
  author={Ladislav {\vS}enolt and Marius H. Braun and Jiri Vencovsky and Liliana {\vS}edov{\'a} and Karel Pavelka},
  journal={Physiological research},
  year={2007},
  volume={56 6},
  pages={771-7}
}
Advanced glycation end-product (AGE) pentosidine has previously been demonstrated in different tissues and body fluids. It was suggested as a novel marker for evaluating the pathologic activity in rheumatoid arthritis (RA). In this study we analyzed the relation between pentosidine and markers of inflammation, cartilage turnover, immune response, and disease status of RA. Using HPLC, we analyzed pentosidine in serum and synovial fluid from 39 patients with RA and in serum from 38 healthy… CONTINUE READING
2 Citations
26 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Similar Papers

Loading similar papers…